Skip to main content
. 2009 Dec;94(12):1661–1668. doi: 10.3324/haematol.2009.010231

Figure 1.

Figure 1.

(A) Relationship between ANC increment and granulocyte dose transfused for the first five non-alloimmunized patients who received 69 granulocyte concentrates. R2=0.26, p<0.01. (B) ANC over time for one patient who developed de novo HLA antibodies during the course of granulocyte therapy. Arrows denote granulocyte transfusions.